Molecular Diagnostics Point of Care Market Analysis & Opportunity Till 2025

Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020

Global Molecular Diagnostics (MDx) Point-of-Care Market Analysis, 2020, By Application (Infectious Disease, Oncology, Hematology, Prenatal Testing, Endocrinology, Others), By Product (Assays, Softwar... ... uct (Assays, Software, Services), By Technology (Isothermal Nucleic Acid Amplification Technology (INAAT), Polymerase Chain Reaction (Digital PCR,, Real Time PCR), Others, By Test-Location (OTC (Over-the-counter), POC (Point-of-care), By End-User (Decentralized Labs, Hospitals, Homecare, Assisted Living Healthcare Facilities, Others), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Mexico, Brazil, Argentina, Germany, France, UK , Spain, Italy, China, Japan, South Korea, India, Australia, Saudi Arabia, UAE) By Company Read more

Healthcare
May 2020
Pages 193
Report Format: PDF, Excel, PPT

Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Molecular Diagnostics (MDx) Point of Care market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

The prevalence of diseases such as infectious diseases in developing countries as well as less developed countries is surging due to improving healthcare infrastructure and the preference of patients for efficient home care. Moreover, suitable government norms and extensive support are also helping in the market growth of MDx Point of Care market. According to MarkNtel Advisors’ research report titled “Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020”, the Global Molecular Diagnostics (MDx) Point of Care market is anticipated to grow at a CAGR of around 13% during 2020-25. However, a lack of arrangement with test results obtained from laboratories, strict & tedious approval policies are expected to restrain the market growth.

Assays are expected to grab the largest market share in the Global Molecular Diagnostics Point of Care market during 2020-25. The assays are uniquely intended for points of care such as hospital critical care units, Specialty clinics, and other healthcare services delivery centers.

North America dominated the Global Mdx Point of Care market in 2019. The same trend is set to prevail during the forecast period. However, the year-on-year growth of Asia-Pacific is set to outperform other geographies during the same period. The region is forecast to grow at a CAGR of around 15.89% during 2020-25, as stated in the MarkNtel Advisors’ research report “Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020”.

According to MarkNtel Advisors, Abbott Laboratories, Mesa Biotech, Hologic, Qiagen, F. Hoffmann, Siemens Healthineers, DxNA, Johnson & Johnson, Roche Diagnostics, Danaher Corporation, EKF Diagnostics, Becton Dickinson, Trinty Biotech, and Quidel are few of the leading players in the Global Molecular Diagnostics (MDx) Point of Care Market.

Introduction
1. Product Definition
2. Research Process
3. Glossary
4. Market Segmentation
Executive Summary
Start-up Ecosystem
Expert Verbatim- Interview Excerpts of 10 industry experts
Global Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Application
    1. Infectious Diseases
    2. Oncology
    3. Hematology
    4. Prenatal Testing
    5. Endocrinology
    6. Others
  2. By Technology
    1. Isothermal Nucleic Acid Amplification Technology (INAAT)
    2. Polymerase Chain Reaction (PCR)
      1. Digital PCR
      2. Real Time PCR
    3. Others
  3. By Product
    1. Assays
    2. Software
    3. Services
  4. By Test-Location
    1. OTC (Over-the-counter)
    2. POC (Point-of-care)
  5. By End-User
    1. Decentralized Labs
    2. Hospitals
    3. Homecare
    4. Assisted Living Healthcare Facilities
    5. Others
  6. By Region
    1. North America
    2. South America
    3. Europe
    4. Asia-Pacific
    5. Middle East & Africa
  7. By Company
    1. Revenue Shares
    2. Strategic Factorial Indexing
    3. Competitor Placement in MarkNtel Quadrant
North America Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Application
  2. By Product
  3. By Test-Location
  4. By End-User
  5. By Technology
  6. By Country
    1. US
    2. Canada
    3. Mexico
3. US Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
4. Canada Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
5. Mexico Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
South America Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Application
  2. By Product
  3. By Test-Location
  4. By End-User
  5. By Country
    1. Brazil
    2. Argentina
    3. Others
3. Brazil Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
4. Argentina Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
Europe Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Application
  2. By Product
  3. By Test-Location
  4. By End-User
  5. By Technology
  6. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Others
3. UK Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
4. Germany Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
5. France Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
6. Italy Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
7. Spain Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
Asia-Pacific Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Application
  2. By Product
  3. By Test-Location
  4. By End-User
  5. By Technology
  6. By Country
    1. China
    2. India
    3. Japan
    4. Australia
    5. South Korea
    6. Others
3. China Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
4. India Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
5. Japan Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
6. Australia Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
7. South Korea Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
Middle East and Africa Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Application
  2. By Product
  3. By Test-Location
  4. By End-User
  5. By Technology
  6. By Country
    1. UAE
    2. Saudi Arabia
    3. Others
3. UAE Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
4. Saudi Arabia Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Application
    2. By End-User
Global Molecular Diagnostics (MDx) Point-of-Care Dynamics
1. Drivers
2. Challenges
3. Impact Analysis
Global Molecular Diagnostics (MDx) Point-of-Care Region Wise Regulations, Product Standards
Global Molecular Diagnostics (MDx) Point-of-Care Hotspots & Opportunities
Competition Outlook
1. Competitor Wise Growth Strategies
  1. Product Portfolio
  2. Brand Specialization
  3. Target Markets
  4. Research & Development
  5. Strategic Alliances & Initiatives
  6. Merges & Acquisitions
2. Company Profiles
  1. Abbott Laboratories
  2. Mesa Biotech
  3. Hologic, Inc.
  4. QIAGEN N.V
  5. F. Hoffmann-La Roche Ltd
  6. DxNA LLC Group Ltd
  7. Luminex Corporation
  8. Siemens Healthineers
  9. Johnson & Johnson
  10. Roche Diagnostics
  11. Danaher Corporation
  12. EKF Diagnostics
  13. Becton Dickison
  14. Trinty Biotech
  15. Quidel Corporation
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying